Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
Titel:
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
Auteur:
Boni, C. Savoldi, L. Bisagni, G. Ceci, G. Crinò, L. De Lisi, V. Di Costanzo, F. Lasagni, L. Manenti, A.L. Moretti, G. Rondini, E. Sassi, M. Zadro, A.